FDA Inspection 957595 — Northampton Hospital Corporation d.b.a. Easton Hospital

Northampton Hospital Corporation d.b.a. Easton Hospital — FEI 3010598266

The FDA completed an inspection of Northampton Hospital Corporation d.b.a. Easton Hospital on February 4, 2016 in Easton, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 4, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Easton, PA (United States)

Additional Details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews
731621 CFR 56.115(a)(4)Copies of IRB/CI correspondence
731921 CFR 56.115(a)(3)Records of continuing review
732121 CFR 56.110(c)Method to keep members advised
733421 CFR 56.115(a)(5)List of members
734321 CFR 56.108(b)(3)Reporting of suspension/termination